0 CHECKOUT

PRODUCT FILTERS

REGION

2
2
2
2

COUNTRY

2
1

CATEGORIES

  • 44
  • 15
  • 9
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

45
45
58
78

PUBLISHED

0
1
2
78

PRODUCT TYPE

71
4
2
1

Search for: "Lorus Therapeutics Incorporated"

78 Products

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  July 2014
Price:  From

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review Summary Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company with focus on the discovery, research and development...

Published:  September 2012
Price:  From

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

“Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...

Published:  February 2010
Price:  From

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant' provides in-depth analysis...

Published:  April 2014
Price:  From

Melanoma - Pipeline Review, H2 2013

Melanoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  August 2013
Price:  From

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

Published:  September 2013
Price:  From

Analysis of Genta Incorporated

Analysis of Genta Incorporated. A complete and comprehensive analysis of Genta Incorporated, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

Published:  April 2013
Price:  From

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

Published:  February 2014
Price:  From

Staphylococcus Aureus Infections - Pipeline Review, H1 2013

Staphylococcus Aureus Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Staphylococcus Aureus Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

Published:  May 2013
Price:  From

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

Published:  May 2014
Price:  From

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

Published:  April 2013
Price:  From

Melanoma - Pipeline Review, H2 2012

Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2012', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

Published:  August 2012
Price:  From

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

Published:  April 2014
Price:  From

Prostate Cancer - Pipeline Review, H2 2014

Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  August 2014
Price:  From

Prostate Cancer - Pipeline Review, H1 2014

Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This...

Published:  June 2014
Price:  From

Melanoma - Pipeline Review, H1 2013

Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  February 2013
Price:  From

Intestinal Cancer - Pipeline Review, H2 2012

Intestinal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2012
Price:  From

Colon Cancer - Pipeline Review, H2 2013

Colon Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  July 2013
Price:  From

Metastatic Melanoma - Pipeline Review, H2 2012

Metastatic Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

Published:  September 2012
Price:  From

Colon Cancer - Pipeline Review, H1 2013

Colon Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  February 2013
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.